Abiopharma

Changes to the Composition of the Board and Board Committees

Change - Announcement of Cessation: Cessation of Non-Independent Non-Executive Director

New Form 4 - LIGAND PHARMACEUTICALS INC Filed: 2025-07-03 AccNo: 0000950170-25-093589 Size: 10 KB

New Form 3 - LIGAND PHARMACEUTICALS INC Filed: 2025-07-03 AccNo: 0000950170-25-093585 Size: 5 KB

New Form 4 - Immuneering Corp Filed: 2025-07-03 AccNo: 0001790340-25-000094 Size: 7 KB

New Form 8-K - LEXICON PHARMACEUTICALS, INC. Filed: 2025-07-03 AccNo: 0001062822-25-000035 Size: 136 KB Item 8.01: Other Events

New Form 8-K - ARDELYX, INC. Filed: 2025-07-03 AccNo: 0001628280-25-034132 Size: 793 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

New Form 6-K - IceCure Medical Ltd. Filed: 2025-07-03 AccNo: 0001213900-25-061233 Size: 23 KB

New Form 424B3 - GT Biopharma, Inc. Filed: 2025-07-03 AccNo: 0001641172-25-017705 Size: 482 KB

New Form 8-K - NorthView Acquisition Corp Filed: 2025-07-03 AccNo: 0001213900-25-061232 Size: 271 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025

ImmunoPrecise - ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data

ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data

New Form 4 - TENAX THERAPEUTICS, INC. Filed: 2025-07-03 AccNo: 0001654954-25-007739 Size: 8 KB